Sign inJoin waitlistJoin the waitlist

Shu Kato

Associate Professor of Medicine · University of California (San Diego) Medical Center

Credentials: · · · ·

History

University of California (San Diego) Medical Center
Present

Albert Einstein College of Medicine
2008–2010
Beth Israel Medical Center-North Division
2005–2008
Nippon Medical School
2001–2005

Research

Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers
Molecular Cancer Therapeutics · 2017 · 1,827 citations
Liquid biopsy: current technology and clinical applications
Review · Journal of Hematology & Oncology · 2022 · 747 citations
Hyperprogressors after Immunotherapy: Analysis of Genomic Alterations Associated with Accelerated Growth Rate
Clinical Cancer Research · 2017 · First of 6 authors · Corresponding · 730 citations

Razelle Kurzrock
146 papers
Jason Sicklick
51 papers · 24 as a resident
JA
Jacob Adashek
30 papers · 30 as a resident
Scott Lippman
26 papers · 3 as a fellow
Hirotaka Miyashita
21 papers · 21 as a fellow
Mina Nikanjam
21 papers · 1 as a fellow
Paul Fanta
21 papers
AG
Aaron Goodman
16 papers · 3 as a fellow
Vivek Subbiah
15 papers
Ramez Eskander
12 papers
Hitendra Patel
11 papers
David Hong
10 papers

Clinical trials

TCF-001 TRACK (Target Rare Cancer Knowledge) Study
Principal investigator · Recruiting
TargetCancer Foundation
2020–2028
Study of Personalized Cancer Therapy to Determine Response and Toxicity
Principal investigator · Recruiting
Shu Mei Kato
2013–2027
Erlotinib in Combination With Pralatrexate in Advanced Malignancies
Principal investigator · Completed · Phase 1
M.D. Anderson Cancer Center
2012–2016
Studying the Safety and Determining the Optimal Dose of Novobiocin in Patients With Tumors That Have Alterations in DNA Repair Genes
Site PI · Recruiting · Phase 1
National Cancer Institute (NCI)
2023–2028